Update of recent reforms in Germany to enhance the quality and efficiency of prescribing of proton pump inhibitors and lipid-lowering drugs.
- 1 May 2009
- journal article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 27 (5), 435-438
- https://doi.org/10.2165/00019053-200927050-00010
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Multifaceted national and regional drug reforms and initiatives in ambulatory care in Sweden: global relevanceExpert Review of Pharmacoeconomics & Outcomes Research, 2009
- Insight into recent reforms and initiatives in Austria: implications for key stakeholdersExpert Review of Pharmacoeconomics & Outcomes Research, 2008
- Trends in generic prescribing and dispensing in EuropeExpert Review of Clinical Pharmacology, 2008
- Overprescribing proton pump inhibitorsBMJ, 2008
- Recent National and Regional Drug Reforms in SwedenPharmacoEconomics, 2008
- Having Your Cake and Eating ItPharmacoEconomics, 2008
- The European Generic Pharmaceutical Market in Review: 2006 and BeyondJournal of Generic Medicines, 2006
- Discontinuation of proton pump inhibitors in patients on long‐term therapy: a double‐blind, placebo‐controlled trialAlimentary Pharmacology & Therapeutics, 2006
- Regulation of pharmaceutical markets in Germany: improving efficiency and controlling expenditures?The International Journal of Health Planning and Management, 2005
- Pharmaceutical regulation in France 1980-2003.The International Journal of Health Planning and Management, 2005